UK and Raleigh, North Carolina-based TRI, a provider of risk-based monitoring solutions for clinical trials, has raised an undisclosed amount of funding. The investor was Octopus Investments, a subsidiary of the Octopus Group.
Source: Press Release
UK and Raleigh, North Carolina-based TRI, a provider of risk-based monitoring solutions for clinical trials, has raised an undisclosed amount of funding. The investor was Octopus Investments, a subsidiary of the Octopus Group.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination